In December 2014, all federally filed Xarelto lawsuits were consolidated into one court in the Eastern District of Louisiana. Now, Judge Eldon Fallon, who has been overseeing the proceedings, has selected four cases to serve as the first bellwether cases. These will represent the thousands…
A new editorial published in Pharmaceutical Journal by Dr. Daniel Marks, Clinical Pharmacologist at University College London Hospital, calls for limiting inappropriate prescribing of proton pump inhibitors (PPIs) , like Nexium and Prilosec, because of the risk of adverse effects. Marks acknowledges
One of the main safety concerns associated with the blood-thinner Xarelto (rivaroxaban) and other similar anticoagulant drugs is that there is no readily available antidote. Patients taking warfarin, the leading anticoagulant for decades, who experience excessive bleeding events, can be treated with
Recent studies have linked popular heartburn drugs like Prevacid and Nexium—so called “proton-pump inhibitors” or PPIs—to side effects like chronic kidney disease, bone fractures, and dependency. Now, a new study published in the International Journal of Basic & Clinical Pharmacology suggests that t
Express Scripts continues to exclude diabetes drug Onglyza from its preferred formulary, listing it as an exclusion for 2017. The prescription benefit plan provider first dropped the medication from its list last year, when it announced that it would no longer provide insurance coverage for…
Proton pump inhibitors (PPIs) like Nexium and Prilosec have been linked in recent studies to a number of potentially dangerous side effects, including bone fractures and chronic kidney disease. A new case study, however, suggests that there may be other concerns, namely, “rhabdomyolysis”, a skeletal
Federally filed testosterone replacement lawsuits have been in centralized litigation in the Northern District of Illinois now for over two years. Parties have been working toward selecting a small number of AndroGel cases that would serve as “test” or “bellwether” trials. These cases would go…
When type 2 diabetes drug Onglyza first came on the market in 2009, manufacturers advertised it as superior to other similar medications. According to a recent study, however, as far as their long-term efficacy and how much these drugs protect patients’ overall health, there isn’t…
In drug-related personal injury lawsuits, plaintiffs often claim that manufacturers engage in aggressive marketing tactics that overstate the benefits of their products while glossing over the potential risks. Such tactics encourage patients to ask their doctors about prescriptions that may or may n
The Centers for Disease Control and Prevention (CDC) has warned that serious gastrointestinal infections from the bacteria Clostridium difficile (or C. diff) have affected nearly half a million people in 2011, with 29,000 dying within 30 days of the initial diagnosis. C. diff. has become…
According to a recent article in the Pennsylvania Record, lawyers for the plaintiffs in consolidated mass tort Xarelto litigation in Philadelphia likened one of the early clinical trials conducted by manufacturers as a “total mess” and similar to a school science fair project. All federally…
American magazine and consumer watchdog Consumer Reports has published two recent reports highlighting the potential health risks associated with proton pump inhibitors (PPIs) like Nexium, Prilosec, and other similar heartburn drugs. These drugs have been linked in studies with bone fractures, depen